Paul Daruwala

Chief Commercial Officer, Cidara Therapeutics.

Companies

Cidara TherapeuticsChief operating officer Apr 2, 2018 to Sep 13, 2022¹
Cidara TherapeuticsChief Commercial Officer Apr 14, 2015 to Sep 19, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cidara Therapeutics CDTX221,099 shares³Sep 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 12, 2022Sold 16,199 shares at $0.68 of Cidara Therapeutics³
Mar 31, 2022Granted 50,000 shares of Cidara Therapeutics⁴
Jan 5, 2022Sold 5,133 shares at $1.25 of Cidara Therapeutics⁵
Dec 29, 2021Exercised options 9,900 shares of Cidara Therapeutics⁵
Sep 30, 2021Granted 132,000 shares of Cidara Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCidara Therapeutics, Chief operating officer
2
SEC EDGARCidara Therapeutics, Chief Commercial Officer
3
SEC EDGARCidara Therapeutics shares after the filing of Sep 12, 2022
4
SEC EDGARForm 4 filed Apr 4, 2022
5
SEC EDGARForm 4 filed Jan 7, 2022
6
SEC EDGARForm 4 filed Oct 4, 2021